Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar bklynmp3j (98.70) Submitted: 8/25/2009 12:23:31 AM : Outperform Start Price: $6.15 INCY Score: +235.95

insider buying

Report this Post Reply

Featured Broker Partners


Advertisement